FLT3-ITD mutation failed to transform primary hematopoietic progenitor cells from CDK6-deficient mice, pointing at CDK6 as the prime target of CDK4/6 inhibitors in AML [93]. The gene discussed is FLT3; the disease is acute myeloid leukemia.